Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An update from Assertio Therapeutics ( (ASRT) ) is now available.
On November 10, 2025, Assertio Holdings, Inc. announced its financial results for the third quarter of 2025, highlighting a significant increase in Rolvedon net product sales, which rose to $38.6 million from $15.0 million in the prior-year quarter. This growth was attributed to both normal demand and large purchases by national distributors. The company also promoted Paul Schwichtenberg to the role of President and Chief Operating Officer, effective November 3, 2025, as part of its strategic efforts to consolidate operations and enhance commercial strategies. Assertio narrowed its full-year 2025 net product sales guidance range to $110 to $112 million and adjusted EBITDA range to $14 to $16 million, reflecting the impact of the Rolvedon pull-forward.
The most recent analyst rating on (ASRT) stock is a Hold with a $1.00 price target. To see the full list of analyst forecasts on Assertio Therapeutics stock, see the ASRT Stock Forecast page.
Spark’s Take on ASRT Stock
According to Spark, TipRanks’ AI Analyst, ASRT is a Neutral.
Assertio Therapeutics faces significant financial challenges, with declining revenues and profitability issues being the most impactful factors. Technical indicators suggest potential undervaluation but bearish momentum. Valuation metrics are weak due to negative earnings. Despite some positive developments from the earnings call, the overall outlook remains cautious.
To see Spark’s full report on ASRT stock, click here.
More about Assertio Therapeutics
Assertio is a pharmaceutical company with comprehensive commercial capabilities offering differentiated products designed to address patients’ needs. The company focuses on marketing products in oncology, neurology, and pain management.
Average Trading Volume: 273,130
Technical Sentiment Signal: Sell
Current Market Cap: $73.19M
Learn more about ASRT stock on TipRanks’ Stock Analysis page.